Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human beta Synuclein ELISA Kit (AC2716)
Cat.#: ASET-1305
Specifications
Description Human beta Synuclein ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human beta Synuclein concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.11 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1946 Human Alpha B Crystallin ELISA Kit (AC3357) Quantitative inquiry ASET-1220 Human CacyBP ELISA Kit (AC2631) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1057 Human COMT ELISA Kit (AC2468) Quantitative inquiry ASET-1397 Human beta III Tubulin ELISA Kit (AC2808) Quantitative inquiry ASET-1944 Human ATP7A ELISA Kit (AC3355) Quantitative inquiry ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-1735 Human NELL1 ELISA Kit (AC3146) Quantitative inquiry ASET-1763 Human IMPA1 ELISA Kit (AC3174) Quantitative inquiry ASET-1234 Rat beta Catenin ELISA Kit (AC2645) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket